What's New
Last Posted: Oct 31, 2019
- Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
Redwood Diana G et al. Journal of primary care & community health 102150132719884295 - Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer.
Yu Haiying et al. Cancer biomarkers : section A of Disease markers 2019 Oct - Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases.
Katsidzira Leolin et al. PloS one 2019 14(10) e0224023 - Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology trainees.
Al Bakir Ibrahim et al. BMJ open 2019 Oct 9(10) e030505 - Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.
Dominguez-Valentin Mev et al. Hereditary cancer in clinical practice 2019 1728 - Cost-effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases.
Peterse Elisabeth F P et al. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019 Oct - Clinical Application of Next-Generation Sequencing as A Liquid Biopsy Technique in Advanced Colorectal Cancer: A Trick or A Treat?
Kastrisiou Myrto et al. Cancers 2019 Oct 11(10) - Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer.
Evrard Camille et al. Cancers 2019 Oct 11(10) - Patients in Whom to Consider Genetic Evaluation and Testing for Hereditary Colorectal Cancer Syndromes.
Kupfer Sonia S et al. The American journal of gastroenterology 2019 Oct - Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer.
López-Cortés Andrés et al. The pharmacogenomics journal 2019 Oct - Precision Treatment and Prevention of Colorectal Cancer-Hope or Hype?
Muller Charles et al. Gastroenterology 2019 Oct - Precision treatment in colorectal cancer: Now and the future.
Yau Tung On et al. JGH open : an open access journal of gastroenterology and hepatology 2019 Oct 3(5) 361-369 - The Colorectal Cancer Risk Assessment Tool
NCI, 2019 - Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie Jeanne, et al. JAMA oncology 2019 10 0. - Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk – current status and future potential
SK Naber et al, JNCI SPectrum, October 17, 2019
.png)
No hay comentarios:
Publicar un comentario